Enzymes in health and diseases final

SumaVenugopal 2,273 views 71 slides May 13, 2020
Slide 1
Slide 1 of 71
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71

About This Presentation

the ppt describes the role of enzymes in health and diseases


Slide Content

Enzymes in health and diseases Presenter : Dr Suma H.V. Moderator : Dr B.G.Malathi

Contents Enzymes- Introduction Functional enzymes Non-functional enzymes Enzyme deficiency disorders Summary References

Enzymes Biological catalysts that speed up the rate of the biochemical reaction enzymes Substrate products

Active site of enzyme The small cleft-like portion of an enzyme where the substrate(s) binds and catalysis occurs is known as the active site or active centre. A diagrammatic representation of an enzyme and its active site

 Enzymes in our body help us in the diagnosis of many diseases. Enzyme in the circulatory system are divided into two groups: 1. Plasma functional enzymes 2. Non-plasma functional enzymes

PLASMA FUNCTIONAL ENZYME Enzymes that are present in plasma and have specific function Activities of these enzymes are higher in plasma than tissues. The are mostly synthesized in liver and enter the circulation. e.g. lipoprotein lipase, cholinesterase, esterase, ceruloplasmin etc.

Impairment of liver function often leads to fall in the activities of plasma function enzyme. e.g. deficiency of ceruloplasmin in Wilson disease.

Non Functional Plasma Enzymes Present in plasma in very low concentration in comparison to tissue. Have no known physiological function in blood.

Increased levels of non functional plasma enzymes in plasma indicates tissue damage. These enzymes can be used for diagnosis.

Source of non functional Plasma enzymes Cell Damage Myocardial infarction and viral hepatitis. Obstruction of Normal pathways: e.g. Obstruction of bile duct increases alkaline phosphatase .

  Medical importance of non functional enzymes Diagnosis of diseases -As disease of different organs cause elevation of different plasma enzymes. Prognosis of the disease To follow up the treatment by measuring plasma enzymes before and after.

Examples of non-functional enzymes Creatine kinase Lactate dehydrogenase Acid phosphatase Amylase Alkaline phosphatase

Cholinesterase( ChE ) Enzymes which hydrolyse esters of choline to give choline and acid. There are two types of cholinesterases . 1.True cholinesterase 2.Pseudo cholinesterase

True Cholinesterase ( Found in nerve tissue and RB cells Responsible for the destruction of acetyl choline (neurotransmitter) at neuromuscular junction

Pseudo cholinesterase Found in various tissues such as liver, heart muscle and intestine. Circulates in plasma. Normal value of pseudo cholinesterase is 2.17 to 5.17 IU/ml.

Organophosphorous insecticides (Parathion) These are organic compounds containing phosphorus, irreversibly inhibit. Their absorption in humans cause poisoning.(neuromuscular damage, muscle weakness, slow breathing) Measurement of ChE level in RBCs is useful to determine the amount of exposure in persons working with these insecticides.

Cholinesterase test To cheque the level of acetyl cholinesterase in RBC and pseudo cholinesterase in plasma. AChE and PChE activity can fall to about 80% of normal before any symptoms appear, of poisoning.

This decrease in activity indicates excessive absorption of organophosphorus compounds, chronic liver disease, renal disease , malnutrition and some cancers.

Lipase It will hydrolyze triglyceride to beta monoglyceride and fatty acid. The enzyme is present in pancreatic secretion. Moderately increased in carcinoma of pancreas, biliary diseases and perforating peptic ulcers.

Highly elevated in acute pancreatitis and this persists for 7–14 days.

Ceruloplasmin / Ferroxidase Copper binding glycoprotein Reference serum level is 25–50 mg/ dL . Increased in all inflammatory conditions, collagen diseases, malignancies and pregnancy.

A value less than 20 mg/ dL is pathognomonic of Wilson’s hepatolenticular degeneration, in which copper toxicity is manifested.

Alpha 1 antitrypsin Synthesized in liver Transported to plasma 100-300mg/dl Protects tissues from inflammatory products eg : Neutrophil elastase in lungs

Increases 1) Inflammation- an acute phase protein 2) Chronic hepatocellular diseases 3) Biliary tract obstruction 4) Pregnancy

Decreases 1) Nephrotic syndrome 2) Emphysema 3) Liver cirrhosis

Liver enzymes Enzymes commonly studied for diagnosis of liver diseases are: Alanine aminotransferase (ALT) Aspartate aminotransferase (AST) Alkaline phosphatase (ALP) Gamma glutamyl transferase (GGT)

Alanine aminotransferase (ALT) Normal serum level : Male is 13–35 U/L Female is 10–30 U/L Rise in ALT levels may be noticed several days before clinical signs such as jaundice are manifested.

ALT Moderate increase (50–100 U/L) of ALT Chronic liver diseases such as cirrhosis, hepatitis C Non-alcoholic steatohepatitis (NASH). Marked increase values (300–1000 U/L) -Acute hepatitis , either toxic or viral in origin.

Aspartate aminotransferase (AST) Normal serum level 8 to 20 U/L. Marker of liver injury Moderate to drastic increase - parenchymal liver diseases like hepatitis and malignancies of liver.

AST was used as a marker of myocardial ischemia in olden days. The level is significantly elevated in myocardial infarction. As AST is raised in various other conditions, the troponins have replaced AST as a diagnostic marker in ischemic heart disease

Alkaline phosphatase (ALP) Produced by osteoblasts of bone, epithelial cells of liver Associated with calcification process. 20-140 IU/L Moderate (2–3 times) increase in ALP level is seen in hepatic diseases such as infective hepatitis, alcoholic hepatitis or hepatocellular carcinoma

Very high levels of ALP (10–12 times of upper limit) Extrahepatic obstruction (obstructive jaundice) caused by gallstones or by pressure on bile duct by carcinoma of head of pancreas. Intrahepatic cholestasis may be due to virus (infective hepatitis) or by drugs (chlorpromazine).

Drastically high levels of ALP (10–25 times of upper limit) Paget’s disease ( osteitis deformans ) Rickets Osteomalacia Osteoblastoma Metastatic carcinoma of bone.

Isoenzymes of alkaline phosphatase Alpha-1 ALP - Synthesized by epithelial cells of biliary canaliculi . - It is about 10% of total activity - Increased in obstructive jaundice.

Isoenzymes of alkaline phosphatase Alpha-2 heat labile ALP - It is produced by hepatic cells.

Alpha-2 heat stable ALP - It is of placental origin. - Not destroyed at 65°C but is inhibited by phenylalanine . Regan isoenzyme or carcino placental isoenzyme .

Isoenzymes of alkaline phosphatase Pre-beta ALP - It is of bone origin - This is heat labile - Elevated levels are seen in bone diseases .

Gamma Glutamyl Transferase (GGT) It is used for the synthesis of glutathione. It is seen in liver, kidney, pancreas, intestinal cells, and prostate gland. Serum value is 10–30 U/L.

It is moderately increased in infective hepatitis and prostate cancers. GGT is clinically important because of its sensitivity to detect alcohol abuse .

Acid Phosphatase Acid phosphatase (ACP) hydrolyses phosphoric acid ester Reference serum value 2.5–12 U/L. Secreted by prostate cells, RBC, platelets and WBC.

The prostate isoenzyme is inactivated by tartaric acid . ACP increased in Prostate cancer Bone metastasis of prostate cancer. In these conditions, the tartrate labile isoenzyme is elevated. This assay is very helpful in follow-up of treatment of prostate cancers. So, ACP is an important tumor marker .

Since blood cells contain excess quantity of ACP, care must be taken to prevent hemolysis while taking blood from the patient.

Amylase This enzyme splits starch to maltose. Activated by calcium and chloride ions. Produced by pancreas and salivary glands. Reference serum value 50–120 IU/L.

Moderate increase in serum levels Chronic pancreatitis Mumps ( parotitis ) Obstruction of pancreatic duct.

Markedly increased levels Acute pancreatitis which is a life-threatening condition. Values peaks between 5–12 hours after the onset of disease and returns to normal levels within 2–4 days after the acute phase has subsided.

Reference value of amylase in urine is less than 375 U/L. It is increased in acute pancreatitis. It is increased on the 1 st day and remains to be elevated for 7–10 days.

Enolase It is a glycolytic enzyme. Neuron-specific enolase (NSE) is an isoenzyme seen in neural tissues and Apudomas .

NSE is a tumor marker for Carcinoid tumor Neuroblastoma Pheochromocytoma Medullary carcinoma of thyroid,

Lactate dehydrogenase Present in heart, brain, liver and skeletal muscle Lactate to pyruvate Normal serum LDH level is 100-200 U/L Any increase in the LDH level suggests tissue damage

Creatine Kinase (CK) -Brain, heart and skeletal muscle. -Normal serum levels of CK - 15 - 100 U/L in males - 10 - 80 U/L in females. -CK-BB -CK-MM -CK-MB -Brain type can indicate a stroke or a brain tumour

-After a heart attack, CK shows up more rapidly in the blood than LDH. In myocardial infarction, CK levels (CK – MB isoenzyme ) start to rise within 3 – 6 hours of infarction.

Monitoring the presence of both enzymes extends the possibility of diagnosis, which is useful, since a very mild heart attack might be difficult to diagnose. An elevated level of the isozyme from heart in blood is a definite indication of damage to the heart tissue

Enzyme deficiency disorders Inherited disorders with loss/ decreased enzyme activity Increased amount of substrate in serum Prenatal diagnosis in amniotic fluid Examples Galactosemia Glucose-6-phosphatase dehydrogenase deficiency Phenylketonuria Albinism, alkaptonuria etc

Glucose-6-phosphate Dehydrogenase Important enzyme in hexose-monophosphate shunt pathway of glucose. Deficiency – inborn error of metabolism X – linked recessive It is mainly used for production of NADPH.

Drug-induced hemolytic anemia : In the GPD deficient individuals, RBC lifespan may be reduced, without disease manifestations. But when they take certain drugs ( aspirin , mepacrine , primaquine , sulpha ), there will be sudden damage to RBCs. Fava beans (star beans, corner beans) may also induce hemolytic anemia which is called favism .

Carrier State has Biological Advantage The gene for GPD is located in X-chromosome . In heterozygous condition, the GPD level in RBC is half the normal value. GPD deficiency seems to protect the person from falciparum malaria . The malarial parasites require NADPH for optimal growth.

Met- hemoglobinemia : NADPH Met-hemoglobin hemoglobin

Galactosemia

Galactose-1-phosphate uridylyltransferase  Classic  galactosemia Inborn error of galactose metabolism Autosomal recessive Symptoms - Jaundice Vomiting Poor weight gain Irritability Seizures

 Phenylalanine hydroxylase Phenylketonuria Genetic disorder inherited. It is due to mutations in the PAH gene This results in the buildup of dietary phenylalanine to potentially toxic levels.

Homogentisate 1,2 - dioxygenase

Albinism

Albinism Genetic condition – X linked recessive Defeciency of tyrosinase Lacks melanin pigment Affects eye, skin, hair

Enzymes as Therapeutic Agents Streptokinase (from Streptococcus) or Urokinase (from urine) can lyse intravascular clots and are therefore used in myocardial infarction. Pepsin and trypsin are given to patients with defective digestion. Asparaginase is used as an anticancer drug. Streptodornase with streptokinase used to facilitate drainage in septic surgical conditions

Enzyme in Diseases I. Hepatic diseases Alanine aminotransferase (ALT): Marked increase in parenchymal liverdiseases Aspartate aminotransferase (AST): Elevated in parenchymal liver disease Alkaline phosphatase (ALP): Marked increase in obstructive liver disease Gamma glutamyl transferase (GGT): Increase in obstructive and alcoholic liver

II. Myocardial infarction Creatine kinase (CK-MB): CK-MB isoenzyme is specific III. Bone diseases Alkaline phosphatase (ALP) Marked elevation in rickets and Paget’s disease

IV. Muscle diseases Creatine kinase (CK-MM): Marked increase in muscle diseases. Aspartate aminotransferase (AST): Increase in muscle disease; not specific Aldolase (ALD): Earliest enzyme to rise, but not specific

V. Prostate cancer Acid phosphatase (ACP): Marker for prostate cancer. Metastatic bone disease especially from a primary form prostate. Inhibited by L tartrate . VI. Pancreatic disease Amylase: Marker for acute pancreatitis and inflammation of salivary glands Lipase: Marker of pancreatitis, more specific than amylase

References Harper’s textbook of biochemistry Textbook of biochemistry . Rafi M D Tietz fundamentals of clinical chemistry

Thank you